Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB26FYM37
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $79,935
Award facts
- Contract value 100% obligated
- $79,934.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $79,934.51 to DMS Pharmaceutical Group Inc. for Keytruda 100 mg/4 mL vials on October 20, 2025, with completion expected by November 10, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price delivery order with no set-aside designation. This award represents a single transaction within the company's broader contractual relationship with the Defense Logistics Agency's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to streamline pharmaceutical sourcing for Department of Defense healthcare facilities worldwide. The underlying IDC, awarded November 13, 2025, carries a $499,999,999 ceiling and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. Keytruda, an oncology treatment, exemplifies the specialized pharmaceutical products DMS Pharmaceutical Group supplies to support military medical operations globally under this prime vendor framework.
Quick answers
Who was awarded contract SPE2DB26FYM37?
SPE2DB26FYM37 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FYM37 worth?
The government has obligated $79,935 on SPE2DB26FYM37.
Is contract SPE2DB26FYM37 an order under another contract?
Yes. SPE2DB26FYM37 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB26FYM37 competed?
The extent of competition for SPE2DB26FYM37 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award